Insider Transactions in Q1 2023 at Illumina, Inc. (ILMN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Scott Gottlieb Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+2.72%
|
$21,000
$210.47 P/Share
|
|
Mar 01
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,074
+16.22%
|
-
|
|
Mar 01
2023
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,926
+34.42%
|
-
|
|
Mar 01
2023
|
Carissa Rollins SVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,037
+43.24%
|
-
|
|
Mar 01
2023
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,926
+41.39%
|
-
|
|
Mar 01
2023
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,917
-57.62%
|
$779,483
$199.06 P/Share
|
|
Mar 01
2023
|
Kevin Carl Pegels Chief of Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,037
+29.28%
|
-
|
|
Mar 01
2023
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,556
+33.82%
|
-
|
|
Mar 01
2023
|
John Edward Frank Chief Public Affairs Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,556
+44.91%
|
-
|
|
Mar 01
2023
|
Joydeep Goswami SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,074
+32.71%
|
-
|
|
Mar 01
2023
|
Francis A De Souza President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
31,480
+20.65%
|
-
|
|
Mar 01
2023
|
Scott D Ericksen VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,637
+17.08%
|
-
|
|
Mar 01
2023
|
Charles Dadswell SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Indirect |
6,926
+28.99%
|
-
|
|
Mar 01
2023
|
Alexander Aravanis SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,074
+43.67%
|
-
|
|
Feb 22
2023
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,398
-40.63%
|
$1,084,998
$201.79 P/Share
|
|
Feb 21
2023
|
Alexander Aravanis SVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,894
-31.88%
|
$786,588
$202.84 P/Share
|
|
Feb 21
2023
|
Alexander Aravanis SVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,292
+43.21%
|
-
|
|
Feb 21
2023
|
Francis A De Souza President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,907
-10.86%
|
$2,203,214
$202.84 P/Share
|
|
Feb 21
2023
|
Francis A De Souza President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,473
+18.95%
|
-
|
|
Feb 21
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,197
-4.98%
|
$443,794
$202.84 P/Share
|
|
Feb 21
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,869
+11.73%
|
-
|
|
Feb 21
2023
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
704
-10.1%
|
$142,208
$202.84 P/Share
|
|
Feb 21
2023
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,789
+28.57%
|
-
|
|
Feb 21
2023
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-16.72%
|
$275,730
$202.84 P/Share
|
|
Feb 21
2023
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,282
+39.29%
|
-
|
|
Feb 21
2023
|
Kevin Carl Pegels Chief of Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
409
-5.43%
|
$82,618
$202.84 P/Share
|
|
Feb 21
2023
|
Kevin Carl Pegels Chief of Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,097
+12.7%
|
-
|
|
Feb 21
2023
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,245
-14.69%
|
$251,490
$202.84 P/Share
|
|
Feb 21
2023
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,522
+29.36%
|
-
|
|
Feb 21
2023
|
Joydeep Goswami SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,640
-13.34%
|
$331,280
$202.84 P/Share
|
|
Feb 21
2023
|
Joydeep Goswami SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,696
+27.64%
|
-
|
|
Feb 21
2023
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,907
-15.96%
|
$385,214
$202.84 P/Share
|
|
Feb 21
2023
|
Charles Dadswell SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Indirect |
5,282
+30.66%
|
-
|
|
Feb 06
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.29%
|
$105,500
$211.57 P/Share
|
|
Jan 09
2023
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
871
-23.75%
|
$178,555
$205.57 P/Share
|
|
Jan 06
2023
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.28%
|
$102,000
$204.58 P/Share
|